Does the US spend more Money Researching diseases affecting men?

Share on facebook
Share on twitter
Share on email

Does the U.S. spend more money researching diseases that primarily affect men? The answer is emphatically yes, according to an article published in the Journal of Women’s Health by Art Mirin, chair of #MEAction’s California State Chapter.

In his research, Dr. Mirin found that the National Institutes of Health (NIH) gives a disproportionate share of its resources to diseases that primarily affect men, at the expense of those that affect primarily women. In nearly three-quarters of the cases where a disease afflicts primarily one sex, the funding pattern favors men – and at twice the funding rate! 

Dr. Mirin analysed the allocation of funds across diseases, and normalized the funding level to disease burden (measured by the Disability Adjusted Life Year). His team categorized a disease as being over-funded if its actual funding exceeded the burden-commensurate value, and under-funded if its actual funding was less.

Of all of the diseases in the NIH portfolio, ME/CFS is the lowest funded disease relative to disease burden by the NIH, and 75 percent of those afflicted are women. 

“Gender bias has been an ongoing issue in health care and has manifested itself in a number of different ways,” wrote Dr. Mirin. “Other examples include the underrepresentation of women in health studies, the trivialization of women’s complaints, and discrimination in the awarding of research grants.”

Jennifer Brea’s TED Talk calling for healthcare providers to believe women and not continue to dismiss them as hysterical struck a chord with Dr. Mirin after doing the research on gender disparity for himself.  

Set Aside Funding, NIH! 

Dr. Mirin said he has no reason to believe that NIH is intentionally short-changing women – rather that we are seeing the result of a structural gender bias, and the first step to change is acknowledging the problem. 

 “The most effective way for NIH to respond to funding disparities, be they based on gender or something else, is to remedy the situation by setting aside funding,” said Mirin. “As we have argued vis-à-vis ME/CFS, a similar approach will likely be needed to address gender disparity.”  

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on email
Email

Leave a Comment

Your email address will not be published. Required fields are marked *

Latest News

In Memory of Dr. Ronald G. Tompkins MD, ScD

Mourning the loss of Dr. Ron Tompkins

Today #MEAction joins the community in mourning the loss of Dr. Ronald G. Tompkins, MD, ScD, who passed away this week. Ron Tompkins was a clinician, clinical researcher, and friend and ally to people with ME. He was the Sumner M. Redstone Professor of Surgery at Harvard Medical School, Founding Director of the Center for

Read More »
National Institutes of Health campus buildings from above

NIH Long COVID research lacks clear plan to identify and track ME/CFS

MEAction has written to the National Institutes of Health (NIH) expressing our deep concern that the RECOVER Initiative research agenda lacks a clear plan for how to accurately identify or consistently track the onset of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) cases among patients with Long COVID. This is of particular importance because a sizable fraction

Read More »

The Last Two Years Changed the World…

What a year 2021 was! People with ME have always faced formidable challenges: every day combatting stigma, lack of understanding from clinicians, NIH’s and CDC’s low budgetary commitments, and a world of challenges navigating disability on top of symptoms.  It’s no exaggeration to say that 2020 and 2021 changed the world – and the world of chronic,

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top